Lucius Bosentan – Buy online

USD 91.47

Sold 400+
Special Offer

Offline Hong Kong pharmacy with 100% genuine product guarantee

Key Highlights

ETA ETB ETA ETB -1 (ET-1) , ETA ETB

Service Promise

Direct from JapanLicensed PharmacyPharmacist CheckedEditable in Admin

Specifications

Specification
125mg*56 tablets
Manufacturer
Lucius Pharmaceuticals
Shipping
Hong Kong

10000 in stock

Product Info

English Name
Bosentan
Generic Name
Bosentan

Specifications

Specification
125mg*56 tablets
Manufacturer
Lucius Pharmaceuticals
Shipping
Hong Kong

Full Details

How It Works

ETA ETB ETA ETB -1 (ET-1) , ETA ETB

Pharmacology

12.1 How It Works ETA ETB ETA ETB -1 (ET-1) , ETA ETB

Dosage

2.1 (REMS), , [ Precautions (5.2)] [ Precautions (5.1, 5.2)] , [ (4.1) Precautions (5.3) (8.1, 8.3)] 2.2 1 , 125 mg

Precautions

5.1 n = 658 11% ALT AST 3 , n = 280 2% 95 125 mg PAH 12% ALT AST 3 ,70 250 mg PAH 14% ALT AST 3 2% PAH 125 mg 7% PAH 250 mg ALT AST 8 658 2 0.3% 3 , PAH n=100 ,2% ≥3×ULN

Drug Interactions

7.1 P450 CYP2C9 CYP3A [ (12.3)] CYP2C9 CYP3A CYP3A ……

Adverse Reactions

Description [ Precautions(5.1)] - [ Precautions(5.3)] [ Precautions(5.4)] 6.1 , , 13 9 4 , 870 8

Storage

62.5 , , , , “446”, NDC 68382-446-14,60 , NDC 68382-446-01,100 NDC 68382-446-28,180 NDC 68382-446-05,500 NDC 68382-446-77,100 10 x 10 ,

Package Insert

Dosage

2.1 (REMS), , [ Precautions (5.2)] [ Precautions (5.1, 5.2)] , [ (4.1) Precautions (5.3) (8.1, 8.3)] 2.2 1 , 125 mg

Adverse Reactions

Description [ Precautions(5.1)] - [ Precautions(5.3)] [ Precautions(5.4)] 6.1 , , 13 9 4 , 870 8

Precautions

5.1 n = 658 11% ALT AST 3 , n = 280 2% 95 125 mg PAH 12% ALT AST 3 ,70 250 mg PAH 14% ALT AST 3 2% PAH 125 mg 7% PAH 250 mg ALT AST 8 658 2 0.3% 3 , PAH n=100 ,2% ≥3×ULN

Drug Interactions

7.1 P450 CYP2C9 CYP3A [ (12.3)] CYP2C9 CYP3A CYP3A ……

Clinical Pharmacology

12.1 How It Works ETA ETB ETA ETB -1 (ET-1) , ETA ETB

Pharmacology and Toxicology

13.1 , 450 mg/kg/ mg/m² [MRHD] 125 mg 8 , , 2000 mg/kg/ MRHD 32 , , 500 mg/kg/ MRHD 16 , ,

Clinical Studies

14.1 WHO III-IV 32 213 (BREATHE-1) , 125 mg , 250 mg (Study 351) , 125 mg WHO III-IV (72%), (21%), (7%)

Storage

62.5 , , , , “446”, NDC 68382-446-14,60 , NDC 68382-446-01,100 NDC 68382-446-28,180 NDC 68382-446-05,500 NDC 68382-446-77,100 10 x 10 ,

Product Reviews (10)

Filter: All Reviews
4.8★★★★★
10 customer reviews8 verified purchases
+o***e· 3 weeks ago
★★★★
+t***3· 1 months ago
Verified Purchase
★★★★★

Description

How It Works

ETA ETB ETA ETB -1 (ET-1) , ETA ETB

Pharmacology

12.1 How It Works ETA ETB ETA ETB -1 (ET-1) , ETA ETB

Dosage

2.1 (REMS), , [ Precautions (5.2)] [ Precautions (5.1, 5.2)] , [ (4.1) Precautions (5.3) (8.1, 8.3)] 2.2 1 , 125 mg

Precautions

5.1 n = 658 11% ALT AST 3 , n = 280 2% 95 125 mg PAH 12% ALT AST 3 ,70 250 mg PAH 14% ALT AST 3 2% PAH 125 mg 7% PAH 250 mg ALT AST 8 658 2 0.3% 3 , PAH n=100 ,2% ≥3×ULN

Drug Interactions

7.1 P450 CYP2C9 CYP3A [ (12.3)] CYP2C9 CYP3A CYP3A ……

Adverse Reactions

Description [ Precautions(5.1)] - [ Precautions(5.3)] [ Precautions(5.4)] 6.1 , , 13 9 4 , 870 8

Storage

62.5 , , , , “446”, NDC 68382-446-14,60 , NDC 68382-446-01,100 NDC 68382-446-28,180 NDC 68382-446-05,500 NDC 68382-446-77,100 10 x 10 ,